Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Filed Chapter 11
Director departure
Appointed director
Quarterly results
K-V Pharmaceutical Co (KV.A) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/25/2013 SC 13G Silver Point Capital L.P. reports a 11% stake in K-V Pharmaceutical Company
01/26/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
04/08/2011 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
04/04/2011 SC 13G KV PHARMACEUTICAL CO reports a 6.1% stake in K-V Pharmaceutical Company
02/24/2011 SC 13G KV PHARMACEUTICAL CO reports a 8.5% stake in K-V Pharmaceutical Company
02/24/2011 SC 13G Partner Fund Management, L.P. reports a 13.1% stake in K-V Pharmaceutical Company
02/12/2010 SC 13G KV PHARMACEUTICAL CO reports a 18.5% stake in KV Pharmaceutical Co / DE /
07/10/2009 SC 13G FMR CORP reports a 10.6% stake in K V PHARMACEUTICAL CO
02/20/2009 SC 13G Form SC 13G -- Statement of acquisition of beneficial ownership by individuals
02/17/2009 SC 13G Form SC 13G -- Statement of acquisition of beneficial ownership by individuals
01/02/2009 SC 13G HBK New York LLC reports a 6.1% stake in K-V Pharmaceutical Company
01/02/2009 SC 13G HBK Master Fund LP reports a 6.1% stake in K-V Pharmaceutical Company
01/02/2009 SC 13G HBK Partners II L.P. reports a 6.1% stake in K-V Pharmaceutical Company
01/02/2009 SC 13G HBK INVESTMENTS L P reports a 6.1% stake in K-V Pharmaceutical Company
01/02/2009 SC 13G HBK Services LLC reports a 6.1% stake in K-V Pharmaceutical Company
01/02/2009 SC 13G HBK Management LLC reports a 6.1% stake in K-V Pharmaceutical Company

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy